Actavis, Others Infriged Endo's Opana Patents, Judge Says
A New York federal judge on Friday ruled that Actavis Inc. and other drug manufacturers infringed most of the claims of Endo Pharmaceuticals Inc.'s patents related to the painkiller Opana ER, ordering...To view the full article, register now.
Already a subscriber? Click here to view full article